Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 76Neoplasm Metastasis 3Advanced Breast Cancer 3Osteoporosis 2Neoplasms, Hormone-Dependent 2Fractures, Bone 2Carcinoma, Lobular 2Carcinoma, Intraductal, Noninfiltrating 2Carcinoma, Ductal, Breast 2Breast Diseases 2Breast Cancer Female 2Arthralgia 2Sexual Dysfunctions, Psychological 1Neurotoxicity Syndromes 1Luminal B/HER2-negative Breast Cancer 1Hormone-receptor-positive Breast Cancer 1Hormone Receptor Positive Breast Carcinoma 1Hormone Receptor Positive Advanced Breast Cancer 1Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer 1HR+/HER2- Early Breast Cancer 1HR+/HER2+ Early Breast Cancer 1Fatigue 1Estrogen Receptor and/or Progesterone Receptor Positive 1Endometrial Neoplasms 1Bulbo-Spinal Atrophy, X-Linked 1Breast Neoplasms, Male 1Breast Carcinoma In Situ 1Breast Cancer Metastatic 1Bone Diseases, Metabolic 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Aromatase Inhibitors 2Zoledronic Acid 1Letrozole 1Hormone Replacement Therapy 1Denosumab 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Fractures, Bone × Aromatase Inhibitors × Breast × Clear all
NCT00111241 2018-12-14

Changes in Knee Articular Cartilage Volume in Women on Aromatase Inhibitors

Monash University

Completed
115 enrolled 6 charts
Breast

Breast Neoplasms, Osteoporosis, Arthralgia, Fractures, Bone

NCT00766532 2012-09-14

Do Aromatase Inhibitors (AIs) Decrease Intestinal Calcium Absorption?

University of Wisconsin, Madison

Phase 4 Completed
12 enrolled 5 charts
Breast

Bone Diseases, Metabolic, Breast Neoplasms, Osteoporosis, Fractures, Bone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡